STERIS plc logo
STESTERIS plc

Free Cash Flow Yield: 4.69%

Is the free cash flow yield high or low?

The free cash flow yield of 4.69% is 75% above its 5-year average of 2.69%, near the high end of its 5-year range (1.61%–4.96%).

As of Friday, June 26, 2026. 20.25% above its 12-month average of 3.90%.

STE Free Cash Flow Yield

STE Free Cash Flow Yield Chart

4.69%
+42.99% 1Y
STE Free Cash Flow Yield

STE Average Free Cash Flow Yield Chart

STE Free Cash Flow Yield

STE Current vs Average Free Cash Flow Yield Chart

STE Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

4.69%

FREE CASH FLOW YIELD AVG TTM

3.90%

FREE CASH FLOW YIELD AVG 3Y

3.13%

FREE CASH FLOW YIELD AVG 5Y

2.69%

FREE CASH FLOW YIELD AVG 10Y

2.92%

FREE CASH FLOW YIELD AVG 15Y

3.11%

FREE CASH FLOW YIELD AVG 20Y

3.40%

CURRENT VS TTM AVG

+20.25%

CURRENT VS 3Y AVG

+49.93%

CURRENT VS 5Y AVG

+74.59%

CURRENT VS 10Y AVG

+60.73%

CURRENT VS 15Y AVG

+50.66%

CURRENT VS 20Y AVG

+38.13%

STE Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
STERIS plc (STE)$20.52B4.69%3.90%3.13%2.69%
Incyte Corporation (INCY)vs ›$21.48B6.52%5.87%4.29%4.08%
Labcorp Holdings Inc. (LH)vs ›$21.83B6.27%5.82%5.23%7.15%
Viatris Inc. (VTRS)vs ›$18.71B9.05%12.33%14.71%16.04%
BioNTech SE (BNTX)vs ›$22.76B6.57%4.16%18.36%19.65%
Quest Diagnostics Incorporated (DGX)vs ›$22.83B5.74%6.22%5.63%7.19%
United Therapeutics Corporation (UTHR)vs ›$23.07B3.97%5.16%5.77%5.81%
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$17.60B10.31%8.79%6.15%5.54%
Moderna, Inc. (MRNA)vs ›$23.71BN/A8.49%9.09%9.09%
Hologic, Inc. (HOLX)vs ›$16.97B5.82%6.28%5.68%7.87%

Yield Comparison

FCF Yield

4.69%

Earnings Yield

3.77%

Dividend Yield

1.20%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow Yield FAQ

What is the free cash flow yield for STERIS plc (STE)?
The free cash flow yield for STE stock is 4.69%.
Is STERIS plc's free cash flow yield high or low?
The free cash flow yield of 4.69% is 75% above its 5-year average of 2.69%, near the high end of its 5-year range (1.61%–4.96%).
What is the TTM average free cash flow yield for STERIS plc (STE)?
The TTM average free cash flow yield for STE stock is 3.90%.
What is the 3Y average free cash flow yield for STERIS plc (STE)?
The 3Y average free cash flow yield for STE stock is 3.13%.
What is the 5Y average free cash flow yield for STERIS plc (STE)?
The 5Y average free cash flow yield for STE stock is 2.69%.
What is the 10Y average free cash flow yield for STERIS plc (STE)?
The 10Y average free cash flow yield for STE stock is 2.92%.
What is the 15Y average free cash flow yield for STERIS plc (STE)?
The 15Y average free cash flow yield for STE stock is 3.11%.
What is the 20Y average free cash flow yield for STERIS plc (STE)?
The 20Y average free cash flow yield for STE stock is 3.40%.

STE Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-254.69%
2026-06-244.77%
2026-06-234.86%
2026-06-224.93%
2026-06-184.88%
2026-06-174.96%
2026-06-164.78%
2026-06-154.80%
2026-06-124.76%
2026-06-114.77%
2026-06-104.75%
2026-06-094.64%
2026-06-084.71%
2026-06-054.65%
2026-06-044.66%
2026-06-034.70%
2026-06-024.71%
2026-06-014.68%
2026-05-294.64%
2026-05-284.31%
2026-05-274.36%
2026-05-264.29%
2026-05-224.29%
2026-05-214.22%
2026-05-204.30%
2026-05-194.33%
2026-05-184.36%
2026-05-154.38%
2026-05-144.30%
2026-05-134.40%
2026-05-124.40%
2026-05-114.60%
2026-05-084.47%
2026-05-074.34%
2026-05-064.33%
2026-05-054.36%
2026-05-044.37%
2026-05-014.33%
2026-04-304.28%
2026-04-294.36%
2026-04-284.22%
2026-04-274.18%
2026-04-244.19%
2026-04-234.15%
2026-04-224.15%
2026-04-214.23%
2026-04-204.10%
2026-04-174.11%
2026-04-164.22%
2026-04-154.19%
2026-04-144.13%
2026-04-134.13%
2026-04-104.17%
2026-04-094.15%
2026-04-084.13%
2026-04-074.23%
2026-04-064.22%
2026-04-024.24%
2026-04-014.22%
2026-03-314.20%
2026-03-304.23%
2026-03-274.23%
2026-03-264.15%
2026-03-254.15%
2026-03-244.19%
2026-03-234.20%
2026-03-204.22%
2026-03-194.26%
2026-03-184.29%
2026-03-174.22%
2026-03-164.24%
2026-03-134.33%
2026-03-124.37%
2026-03-114.19%
2026-03-104.18%
2026-03-094.08%
2026-03-064.03%
2026-03-053.89%
2026-03-043.82%
2026-03-033.81%
2026-03-023.75%
2026-02-273.68%
2026-02-263.64%
2026-02-253.69%
2026-02-243.76%
2026-02-233.76%
2026-02-203.70%
2026-02-193.70%
2026-02-183.72%
2026-02-173.78%
2026-02-133.74%
2026-02-123.80%
2026-02-113.81%
2026-02-103.79%
2026-02-093.78%
2026-02-063.68%
2026-02-053.99%
2026-02-043.68%
2026-02-033.72%
2026-02-023.68%
2026-01-303.71%
2026-01-293.72%
2026-01-283.73%
2026-01-273.70%
2026-01-263.70%
2026-01-233.75%
2026-01-223.73%
2026-01-213.72%
2026-01-203.77%
2026-01-163.62%
2026-01-153.63%
2026-01-143.68%
2026-01-133.74%
2026-01-123.73%
2026-01-093.79%
2026-01-083.73%
2026-01-073.75%
2026-01-063.74%
2026-01-053.79%
2026-01-023.89%
2025-12-313.84%
2025-12-303.81%
2025-12-293.80%
2025-12-263.81%
2025-12-243.81%
2025-12-233.81%
2025-12-223.81%
2025-12-193.83%
2025-12-183.87%
2025-12-173.87%
2025-12-163.84%
2025-12-153.83%
2025-12-123.86%
2025-12-113.85%
2025-12-103.76%
2025-12-093.78%
2025-12-083.72%
2025-12-053.70%
2025-12-043.73%
2025-12-033.75%
2025-12-023.75%
2025-12-013.70%
2025-11-283.65%
2025-11-263.65%
2025-11-253.63%
2025-11-243.70%
2025-11-213.70%
2025-11-203.79%
2025-11-193.82%
2025-11-183.79%
2025-11-173.79%
2025-11-143.77%
2025-11-133.74%
2025-11-123.63%
2025-11-113.65%
2025-11-103.68%
2025-11-073.69%
2025-11-063.74%
2025-11-053.78%
2025-11-043.80%
2025-11-033.88%
2025-10-313.90%
2025-10-303.89%
2025-10-293.89%
2025-10-283.81%
2025-10-273.82%
2025-10-243.82%
2025-10-233.80%
2025-10-223.80%
2025-10-213.80%
2025-10-203.80%
2025-10-173.83%
2025-10-163.83%
2025-10-153.89%
2025-10-143.87%
2025-10-133.91%
2025-10-103.90%
2025-10-093.84%
2025-10-083.80%
2025-10-073.81%
2025-10-063.82%
2025-10-033.79%
2025-10-023.80%
2025-10-013.81%
2025-09-303.72%
2025-09-293.75%
2025-09-263.69%
2025-09-253.77%
2025-09-243.74%
2025-09-233.69%
2025-09-223.68%
2025-09-193.70%
2025-09-183.67%
2025-09-173.70%
2025-09-163.71%
2025-09-153.71%
2025-09-123.68%
2025-09-113.64%
2025-09-103.77%
2025-09-093.70%
2025-09-083.70%
2025-09-053.75%
2025-09-043.78%
2025-09-033.79%
2025-09-023.80%
2025-08-293.75%
2025-08-283.76%
2025-08-273.69%
2025-08-263.70%
2025-08-253.70%
2025-08-223.65%
2025-08-213.72%
2025-08-203.69%
2025-08-193.71%
2025-08-183.76%
2025-08-153.75%
2025-08-143.74%
2025-08-133.72%
2025-08-123.77%
2025-08-113.81%
2025-08-083.79%
2025-08-073.89%
2025-08-063.56%
2025-08-053.52%
2025-08-043.45%
2025-08-013.47%
2025-07-313.48%
2025-07-303.44%
2025-07-293.45%
2025-07-283.48%
2025-07-253.42%
2025-07-243.47%
2025-07-233.49%
2025-07-223.52%
2025-07-213.54%
2025-07-183.49%
2025-07-173.51%
2025-07-163.46%
2025-07-153.44%
2025-07-143.49%
2025-07-113.45%
2025-07-103.41%
2025-07-093.41%
2025-07-083.39%
2025-07-073.38%
2025-07-033.32%
2025-07-023.31%
2025-07-013.25%
2025-06-303.28%
2025-06-273.30%
2025-06-263.30%
2025-06-253.28%
2025-06-243.29%
2025-06-233.33%
2025-06-203.34%
2025-06-183.33%
2025-06-173.32%
2025-06-163.27%
2025-06-133.26%
2025-06-123.25%

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Mentor, OH
17,840 employees
Healthcare / Medical - Equipment & Services
Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Daniel A. Carestio